Product image of Nexplanon (Etonogestrel) supplied by GNH India

Nexplanon

Active Ingredient:
Etonogestrel
Origin:
EU

Nexplanon (Etonogestrel)

Etonogestrel, the active ingredient in Nexplanon, is a progestin presented as a 68 mg subcutaneous implant for subcutaneous use. It provides long‑acting hormonal contraception by preventing ovulation and altering cervical mucus, and is indicated for women of reproductive age seeking reliable pregnancy prevention.

GNH India supplies Nexplanon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support safe distribution across global markets, including temperature‑controlled shipping where required.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Etonogestrel, a progestin hormonal contraceptive, is used to prevent pregnancy by suppressing ovulation and modifying cervical mucus.
  • Prevention of pregnancy: provides up to three years of continuous contraception after insertion of the subcutaneous implant.
  • Long‑acting reversible contraception: eliminates the need for daily pills, patches, or rings, offering a discreet method.
  • Family planning: suitable for women who desire a reliable, low‑maintenance birth control option.

How It Works

  • Etonogestrel exerts its contraceptive effect by binding to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. It also induces thickening of cervical mucus, reducing sperm penetration, and produces endometrial changes that are unfavorable for implantation. These combined actions maintain a hormonal environment that prevents fertilization and implantation throughout the implant’s lifespan without requiring daily adherence.

Side Effects

Etonogestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Irregular bleeding: changes in menstrual pattern, spotting or amenorrhea.
  • Headache: mild to moderate intensity.
  • Weight gain: modest increase in body weight.
  • Acne: new or worsening skin lesions.

Serious or Rare Side Effects

  • Thromboembolic events: deep vein thrombosis or pulmonary embolism.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Pregnancy while using: ectopic or unintended pregnancy.

Precautions & Warnings

Before prescribing Nexplanon, clinicians should evaluate patient history and consider specific safety measures.

  • Assess cardiovascular risk: avoid in women with a history of thromboembolism.
  • Screen for liver disease: contraindicated in severe hepatic impairment.
  • Evaluate smoking status: caution in smokers over 35 years.
  • Consider bone health: monitor if risk factors for osteoporosis exist.
  • Counsel on insertion and removal: performed by trained healthcare professional.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Etonogestrel can interact with other medicines that affect hormone metabolism or increase clotting risk.

Major Interactions (Avoid)

  • Enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive efficacy.
  • Anticoagulants (e.g., warfarin): may increase bleeding risk.

Moderate Interactions (Monitor Closely)

  • Antiepileptics (e.g., phenytoin): may modestly lower hormone levels.
  • Antiretrovirals (e.g., efavirenz): may decrease effectiveness.
  • Herbal supplements (e.g., St. John’s wort): may reduce plasma concentrations.

Frequently Asked Questions

Nexplanon is a subcutaneous implant that provides hormonal contraception. It is indicated for the prevention of pregnancy in women of reproductive age, offering a long‑acting, reversible method that does not require daily dosing.

Etonogestrel, the progestin in Nexplanon, binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby preventing ovulation. It also thickens cervical mucus and alters the endometrium, creating conditions that are unfavorable for fertilisation and implantation.

The prescribed dose of Nexplanon is determined by a qualified healthcare professional. Each implant contains 68 mg of etonogestrel and is designed to release the hormone steadily for up to three years, after which it should be removed or replaced.

Nexplanon is not intended for use during an existing pregnancy and should be removed if pregnancy occurs. Its safety in breastfeeding women has not been fully established; clinicians usually assess the risk‑benefit profile before prescribing it to nursing mothers.

To order Nexplanon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Unlike oral contraceptive pills, Nexplanon provides continuous hormone delivery for up to three years without daily adherence. Compared with intrauterine devices, it is inserted subcutaneously rather than intrauterinely, offering a discreet option that does not involve a uterine procedure, while still delivering progestin‑only contraception.

Nexplanon should be stored at ambient temperature, preferably below 25 °C. Keep the implant in its original packaging, protect it from moisture and direct sunlight, and avoid exposing it to extreme temperatures that could affect the integrity of the drug.

Nexplanon is inserted subcutaneously in the upper arm by a trained healthcare professional using a sterile applicator. The procedure is performed in an outpatient setting, and the implant remains in place for up to three years before removal or replacement is required.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions that may lead to anaphylaxis, and rare cases of hepatic dysfunction. Women should be monitored for signs of these conditions and advised to seek immediate medical attention if they occur.

Nexplanon is contraindicated in women with a history of thromboembolic disorders, severe liver disease, known hypersensitivity to etonogestrel or any component of the implant, and in those who are currently pregnant. Caution is also advised for smokers over 35 years and for individuals with uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Etonogestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT